Cargando…

Optimization, Production, Purification and Characterization of HIV-1 GAG-Based Virus-like Particles Functionalized with SARS-CoV-2

Virus-like particles (VLPs) constitute a promising approach to recombinant vaccine development. They are robust, safe, versatile and highly immunogenic supra-molecular structures that closely mimic the native conformation of viruses without carrying their genetic material. HIV-1 Gag VLPs share simil...

Descripción completa

Detalles Bibliográficos
Autores principales:	Boix-Besora, Arnau, Lorenzo, Elianet, Lavado-García, Jesús, Gòdia, Francesc, Cervera, Laura
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8874421/ https://www.ncbi.nlm.nih.gov/pubmed/35214708 http://dx.doi.org/10.3390/vaccines10020250

Ejemplares similares

Gag Virus-like Particles Functionalized with SARS-CoV-2 Variants: Generation, Characterization and Recognition by COVID-19 Convalescent Patients’ Sera
por: Boix-Besora, Arnau, et al.
Publicado: (2023)

A Four-Step Purification Process for Gag VLPs: From Culture Supernatant to High-Purity Lyophilized Particles
por: González-Domínguez, Irene, et al.
Publicado: (2021)

Differential N‐ and O‐glycosylation signatures of HIV‐1 Gag virus‐like particles and coproduced extracellular vesicles
por: Lavado‐García, Jesús, et al.
Publicado: (2022)

Characterization and quantitation of fluorescent Gag virus-like particles
por: Gutiérrez-Granados, Sonia, et al.
Publicado: (2013)

An Alternative Perfusion Approach for the Intensification of Virus-Like Particle Production in HEK293 Cultures
por: Lavado-García, Jesús, et al.
Publicado: (2020)

Corrigendum: An Alternative Perfusion Approach for the Intensification of Virus-Like Particle Production in HEK293 Cultures
por: Lavado-García, Jesús, et al.
Publicado: (2021)

At‐line multi‐angle light scattering detector for faster process development in enveloped virus‐like particle purification
por: Pereira Aguilar, Patricia, et al.
Publicado: (2019)

Chimeric VLPs Based on HIV-1 Gag and a Fusion Rabies Glycoprotein Induce Specific Antibodies against Rabies and Foot-and-Mouth Disease Virus
por: Fontana, Diego, et al.
Publicado: (2021)

Quality Assessment of Virus-Like Particles at Single Particle Level: A Comparative Study
por: González-Domínguez, Irene, et al.
Publicado: (2020)

Production of virus-like particles for vaccines
por: Fuenmayor, J., et al.
Publicado: (2017)

Integrating nanoparticle quantification and statistical design of experiments for efficient HIV-1 virus-like particle production in High Five cells
por: Puente-Massaguer, Eduard, et al.
Publicado: (2020)

Optimization of HEK 293 cell growth by addition of non-animal derived components using design of experiments
por: Cervera, Laura, et al.
Publicado: (2011)

Molecular mechanisms by which HERV-K Gag interferes with HIV-1 Gag assembly and particle infectivity
por: Monde, Kazuaki, et al.
Publicado: (2017)

Immunological Characterization of Plant-Based HIV-1 Gag/Dgp41 Virus-Like Particles
por: Kessans, Sarah A., et al.
Publicado: (2016)

Transduction of HEK293 Cells with BacMam Baculovirus Is an Efficient System for the Production of HIV-1 Virus-like Particles
por: Puente-Massaguer, Eduard, et al.
Publicado: (2022)

Optimizing the synthesis and purification of MS2 virus like particles
por: Hashemi, Khadijeh, et al.
Publicado: (2021)

ESCRT-Independent Budding of HIV-1 Gag Virus-Like Particles from Saccharomyces cerevisiae Spheroplasts
por: Norgan, Andrew P., et al.
Publicado: (2012)

Gag-Gag Interactions Are Insufficient to Fully Stabilize and Order the Immature HIV Gag Lattice
por: Saha, Ipsita, et al.
Publicado: (2021)

FRET analysis of HIV‐1 Gag and GagPol interactions
por: Takagi, Shimon, et al.
Publicado: (2017)

Biological and biochemical characterization of HIV-1 Gag/dgp41 virus-like particles expressed in Nicotiana benthamiana
por: Kessans, Sarah A, et al.
Publicado: (2013)

Correction: ESCRT-Independent Budding of HIV-1 Gag Virus-Like Particles from Saccharomyces cerevisiae Spheroplasts
por: Norgan, Andrew P., et al.
Publicado: (2013)

An engineered HIV-1 Gag-based VLP displaying high antigen density induces strong antibody-dependent functional immune responses
por: Tarrés-Freixas, Ferran, et al.
Publicado: (2023)

Author Correction: Optimizing the synthesis and purification of MS2 virus like particles
por: Hashemi, Khadijeh, et al.
Publicado: (2022)

Immunogenicity of HIV-1 Vaccines Expressing Chimeric Envelope Glycoproteins on the Surface of Pr55 Gag Virus-Like Particles
por: Chapman, Rosamund, et al.
Publicado: (2020)

Modulation of HIV-1 Gag/Gag-Pol frameshifting by tRNA abundance
por: Korniy, Natalia, et al.
Publicado: (2019)

Effects of reduced gag cleavage efficiency on HIV-1 Gag-Pol package
por: Lin, Yi-Ru, et al.
Publicado: (2022)

New Insights into HTLV-1 Particle Structure, Assembly, and Gag-Gag Interactions in Living Cells
por: Fogarty, Keir H., et al.
Publicado: (2011)

Generation of a Recombinant Gag Virus-Like-Particle Panel for the Evaluation of p24 Antigen Detection by Diagnostic HIV Tests
por: Vetter, Beatrice N., et al.
Publicado: (2014)

New insights into retroviral Gag–Gag and Gag–membrane interactions
por: Maldonado, José O., et al.
Publicado: (2014)

P10-10. HIV-1 Gag virus like particles pseudotyped with CD40 ligand to stimulate innate immune responses
por: Köstler, J, et al.
Publicado: (2009)

Identification of a Structural Element in HIV-1 Gag Required for Virus Particle Assembly and Maturation
por: Novikova, Mariia, et al.
Publicado: (2018)

Exosomes and HIV Gag bud from endosome-like domains of the T cell plasma membrane
por: Booth, Amy M., et al.
Publicado: (2006)

Plasma Membrane Anchoring and Gag:Gag Multimerization on Viral RNA Are Critical Properties of HIV-1 Gag Required To Mediate Efficient Genome Packaging
por: Duchon, Alice, et al.
Publicado: (2021)

Stability studies of HIV-1 Pr55(gag) virus-like particles made in insect cells after storage in various formulation media
por: Lynch, Alisson, et al.
Publicado: (2012)

Induction of HIV-specific T-cell responses by gag
por: Van Gulck, Ellen, et al.
Publicado: (2006)

Role of Gag in HIV Resistance to Protease Inhibitors
por: Clavel, François, et al.
Publicado: (2010)

A heterologous prime-boosting strategy with replicating Vaccinia virus vectors and plant-produced HIV-1 Gag/dgp41 virus-like particles
por: Meador, Lydia R., et al.
Publicado: (2017)

Reviewing HIV-1 Gag Mutations in Protease Inhibitors Resistance: Insights for Possible Novel Gag Inhibitor Designs
por: Su, Chinh Tran-To, et al.
Publicado: (2019)

HIV-1 Gag release from yeast reveals ESCRT interaction with the Gag N-terminal protein region
por: Meusser, Birgit, et al.
Publicado: (2021)

Trans-packaging of human immunodeficiency virus type 1 genome into Gag virus-like particles in Saccharomyces cerevisiae
por: Tomo, Naoki, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_nnq0cb2m2b8t8sctjh47c75r0u